Wang v. Zymergen Inc.

CourtDistrict Court, N.D. California
DecidedFebruary 26, 2024
Docket5:21-cv-06028
StatusUnknown

This text of Wang v. Zymergen Inc. (Wang v. Zymergen Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Wang v. Zymergen Inc., (N.D. Cal. 2024).

Opinion

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 BIAO WANG, et al., Case No. 21-cv-06028-PCP

8 Plaintiffs, ORDER GRANTING LEAVE TO 9 v. AMEND

10 ZYMERGEN INC., et al., Re: Dkt. No. 234 Defendants. 11

12 13 Lead plaintiff Biao Wang has moved for leave to file a second amended complaint. Dkt. 14 No. 234. For the reasons that follow that motion is granted. 15 I. Background 16 The current operative complaint in this case, Dkt. No. 78, was filed February 24, 2022. It 17 includes a claim under Section 11 of the Securities Act against Zymergen, a group of individual 18 defendants, and a group of underwriter defendants; as well as a claim under Section 15 of the 19 Securities Act against the individual defendants and a third set of defendants, the controlling 20 stockholders, which included a group of SoftBank parties,1 a group of DCVC parties,2 and a group 21 of True Ventures parties.3 On November 29, 2022 the Court dismissed the Section 15 claim on the 22 basis that there were not “sufficient allegations to suggest that the ‘Controlling Stockholders’ 23 acted in concert.” Dkt. No. 162, at 4. That dismissal was with leave to amend: The Court ordered 24 that “[a]ny amended complaint is due within 28 days,” but also directed that “if the plaintiffs wish 25

26 1 SVF Excalibur (Cayman) Limited; SVF Endurance (Cayman) Limited; and SoftBank Vision Fund (AIV M1) L.P. 27 2 Data Collective II, L.P. and DCVC Opportunity Fund, L.P. 1 to proceed on this complaint, they can always seek leave to amend at a later stage if discovery 2 reveals additional information relevant to the dismissed claims.” Id. Plaintiffs did not file an 3 amended complaint within 28 days of that order. Shortly thereafter, the Court entered a scheduling 4 order setting a deadline of December 21, 2023 to amend pleadings. Dkt. No. 167. 5 On December 21, 2023—the amendment deadline—Mr. Wang filed the present motion for 6 leave to file a second amended class action complaint. He attached a proposed complaint to his 7 motion. The proposed complaint would replead the previously dismissed Section 15 claims against 8 the three sets of controlling stockholders. Mr. Wang says the proposed additions are based on 9 discovery obtained to date. The proposed complaint would also add claims against the investment 10 management companies for the three sets of funds. The underwriter defendants do not oppose 11 leave to amend. Dkt. No. 240. The individual defendants filed an opposition. Dkt. No. 244. The 12 controlling stockholders who would be re-added as defendants filed motions to intervene for the 13 limited purpose of opposing Mr. Wang’s motion for leave to amend. Dkt. Nos. 248, 250, 255. The 14 Court granted these motions and accepted the controlling stockholders’ opposition briefs, Dkt. 15 Nos. 292, 296, 299, to consider arguments specific to the motion for leave to amend that those 16 parties would not be able to raise in a subsequent motion to dismiss. Dkt. No. 283. 17 II. Legal Standard 18 Rule 15 provides that for amendments not allowed as a matter of course “a party may 19 amend its pleading only with the opposing party’s written consent or the court’s leave.” It directs 20 that a “court should freely give leave when justice so requires.” The Ninth Circuit has counseled 21 that “leave to amend should be granted with extreme liberality.” Brown v. Stored Value Cards, 22 Inc., 953 F.3d 567, 574 (9th Cir. 2020) (cleaned up). The Court considers several factors in 23 determining whether to permit amendment, including “undue delay, the movant’s bad faith or 24 dilatory motive, repeated failure to cure deficiencies by amendments previously allowed, undue 25 prejudice to the opposing party, and futility.” Id. Of these, “prejudice to the opposing party carries 26 the most weight.” Id. 27 1 III. Analysis 2 The defendants and would-be defendants who oppose leave to amend have not 3 demonstrated the kind of delay, bad faith, or prejudice that would warrant not letting Mr. Wang 4 amend his complaint given the liberal standard of Rule 15 and the Court’s previous order that 5 specifically contemplated Mr. Wang re-adding the Section 15 claims based on discovery. 6 Although the defendants also attack the merits of Mr. Wang’s proposed new claims and contend 7 that amendment would be futile, their arguments will be better addressed in the context of a fully 8 briefed motion to dismiss the second amended complaint. 9 A. Delay 10 The delay inquiry focuses on whether the party seeking to amend a pleading has waited 11 unreasonably long to do so. It considers “whether the moving party knew or should have known 12 the facts and theories raised by the amendment in the original pleading,” as well as the “delay 13 between the time of obtaining a relevant fact and seeking a leave to amend.” AmerisourceBergen 14 Corp. v. Dialysist W., Inc., 465 F.3d 946, 953 (9th Cir. 2006). 15 None of the opposing parties argues that Mr. Wang knew or should have known the facts 16 he proposes in his amendment at the time he filed his initial complaint. Instead, they argue that he 17 unreasonably delayed seeking to amend his complaint after learning of new facts in discovery. Mr. 18 Wang has obtained more than 1.6 million pages of documents in discovery, according to his 19 counsel, including 500,000 pages produced after June 6, 2023 and 250,000 after November 23, 20 2023. Dkt. No. 310, at 2. Even assuming the revelations relevant to Mr. Wang’s proposed 21 amendment were all produced on or before June 6, 2023, as at least the individual defendants 22 argue, Dkt. No. 244, at 9, there is no indication that Mr. Wang unreasonably delayed in bringing 23 his motion for leave to amend by December 2023, especially given the quantity of documents at 24 issue. It is not necessarily unreasonable for a plaintiff to wait to see what further documents will 25 be produced while discovery is ongoing, even after receiving some new information that may be 26 relevant. Especially given the Court’s previous dismissal of the Section 15 claims, Mr. Wang 27 cannot be faulted for waiting to gather as much additional information as possible before 1 order specifically contemplated he could. 2 Some of the opposing parties also argue that Mr. Wang’s proposed amendment will cause 3 undue delay by requiring another round of briefing on another motion to dismiss. But this is not 4 the kind of delay courts consider when determining whether to grant leave to amend under Rule 5 15. Amending pleadings will almost always result in some degree of prospective delay. This is 6 part of the reason why Rule 16 requires the Court to set a deadline for amending pleadings. Here, 7 though, Mr. Wang has specifically complied with that deadline and has not unreasonably delayed 8 bringing his motion for leave to amend. 9 B. Motive 10 The Court can also consider a movant’s “bad faith or dilatory motive” in determining 11 whether to grant leave to amend. Here, none of the opposing parties explicitly argues that Mr. 12 Wang is acting in bad faith or out of motivation to delay this case. But some of the opposing 13 parties assert that Mr. Wang’s motion may be motivated by additional strategic considerations. For 14 example, SoftBank suggests that Mr. Wang’s motion “looks to be an effort to bring additional 15 parties into the case to increase leverage or improve chances of financial recovery.” Dkt. No. 299, 16 at 20. True Ventures put it more bluntly: “Plaintiff’s true motivation” is “to get at the ostensible 17 deep pockets of Zymergen investors following the Company’s bankruptcy announcement.” Dkt. 18 No. 296, at 21.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Wang v. Zymergen Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/wang-v-zymergen-inc-cand-2024.